Osha.Guidelines for cytotoxic (antineoplastic) drugs. Washington, DC: Department of Labor, Occupational Safety and Health Administration, Office of Occupational Medicine Publication No. 8—1.1. 1986.
2.
ASHP (American Society of Hospital Pharmacists).ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm1990;47: 1033—49.
3.
Osha.OSHA Instruction TED (training and education directive), 1.15 directorate of technical support: controlling occupational exposure to hazardous drugs. Washington, DC: Occupational Safety and Health Administration. 1995.
4.
NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings2004. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No 2004—165.
5.
ASHP (American Society of Health System Pharmacists).Guidelines on handling hazardous drugs. Am J Health Syst Pharm2006; 63: 1172—93.
6.
Turci R., Sottani C., Spagnoli G., Minoia C.Biological and environmental monitoring of hospital personnel exposed to antineoplastic agent: a review of analytical methods. J Chromatogr B Biomed Sci Appl2003; 789: 169—209.
